--------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities and Exchange Act of 1934
Date of Report (Date of earliest event reported): July 1, 2003
GERON CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 0-20859 75-2287752
(State or Other Jurisdiction (Commission File Number) (IRS Employer
of Incorporation) Identification Number)
230 Constitution Drive
Menlo Park, California 94025
(Address of principal executive offices) (Zip Code)
(650) 473-7700
(Registrant's telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS
On July 1, 2003, the Registrant publicly disseminated a press release
announcing that the Registrant had completed its research collaboration with
Celera Genomics Group, an Applera Corporation business. Geron and Celera
collaborated to sequence, identify, and analyze the function of genes expressed
in human embryonic stem cells (hESCs), both in their undifferentiated state and
in the course of their differentiation.
The foregoing description is qualified in its entirety by reference to the
Registrant's Press Release dated July 1, 2003, a copy of which is attached
hereto as Exhibit 99.1.
ITEM 7. EXHIBITS
(c) Exhibits.
99.1 Registrant's Press Release dated July 1, 2003.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
GERON CORPORATION
Date: July 1, 2003 By: /s/ William D. Stempel
-----------------------------------
Name: William D. Stempel
Title: Vice President and General Counsel